2026 Emerging Topic Conference: Unified Frontiers in Liver Disease - Treating Steatosis, Cholestasis, and Beyond

2026 Emerging Topic Conference: Unified Frontiers in Liver Disease - Treating Steatosis, Cholestasis, and Beyond is organized by American Association for the Study of Liver Diseases (AASLD) and will be held from Mar 13 - 15, 2026 at Four Seasons Hotel Las Vegas, Las Vegas, Nevada, United States of America.

Description:
Unified Frontiers in Liver Disease — Treating Steatosis, Cholestasis, and Beyond
Take part in three days of the most progressive discussion on liver disease care with global experts.

Day 1 kicks off with a deep clinical focus on cholestatic liver diseases, diving into current and emerging approaches for primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC). Explore real-world management challenges, new therapeutic targets, and the latest in patient stratification and care redesign.

Days 2–3 shift to the rapidly evolving landscape of steatotic liver disease (SLD), spotlighting MASLD, MetALD, and the latest in SLD research and care. Dive into exciting advancements in noninvasive diagnostics, fibrosis staging, and therapeutic development. Explore how cutting-edge science is reshaping our understanding of metabolic and environmental contributors—and what that means for real-world patient care.

Learning Objectives:

• Examine emerging therapeutic strategies in cholestatic and steatotic liver diseases.
• Explore the metabolic, genetic, and environmental factors driving liver pathogenesis.
• Assess evolving concepts in MASLD, MetALD, and their clinical implications.
• Redesign clinical approaches for diagnosis and treatment using biomarker-driven strategies.
• Evaluate the efficacy and limitations of current and experimental treatment pathways.
• Engage with future-forward topics, including digital pathology and translational research.